Skip to main navigation Skip to search Skip to main content

Pharmacological treatment of obesity

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

4 Scopus citations

Abstract

Obesity is a chronic disease resulting in major morbidity and premature death globally. Current pharmacological treatments are not fully acceptable because of their poor safety and efficacy. Obesity is also associated with other serious complications such as diabetes mellitus, hypertension, hyperlipidemia, hypercholesterolemia, cardiovascular disease etc. Because of its complex nature there is a need for safe and efficacious long-term pharmacological treatment. One treatment approach is not sufficient to manage complex pathological circuitry of obesity. Recently, several novel targets have been proposed that control energy homeostasis and prevent obesity. Although, newer drugs are years away from clinical use, the hope for research investments made to date is translation into safe and effective pharmacological treatment in the future. The goal of this chapter is to describe the latest strategies of pharmacological treatment that are under development, which may finally be used in future.

Original languageEnglish
Title of host publicationSleep Loss and Obesity
Subtitle of host publicationIntersecting Epidemics
PublisherSpringer New York
Pages203-225
Number of pages23
ISBN (Electronic)9781461434924
ISBN (Print)9781461434917
DOIs
StatePublished - 1 Jan 2012
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Pharmacological treatment of obesity'. Together they form a unique fingerprint.

Cite this